Systemic Therapy for Mucosal, Acral, and Uveal Melanoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2020-01-29

AUTHORS

Suthee Rapisuwon , Yong Qin , Jason Roszik , Fernando Carapeto , Sapna Patel , Richard D. Carvajal

ABSTRACT

Melanoma is a disease that is remarkably heterogeneous. Even cutaneous melanoma, the most common melanoma subtype, is characterized by important biological and clinical differences between disease arising from nonchronically sun-exposed and chronically sun-exposed skin. Acral melanoma, melanomas which arise from skin on the palms of the hands, soles of the feet, or beneath the nails of the fingers or toes, and extracutaneous melanomas, such as those arising from the mucosal surfaces of the body and from the uveal tract of the eye, are uncommon melanoma subtypes also characterized by biological and clinical characteristics distinct from non-acral cutaneous melanoma and distinct from one another. These melanoma subtypes share a more aggressive natural history as well as a lack of association with ultraviolet radiation when compared with non-acral cutaneous disease.Because of the rarity of acral and extracutaneous melanomas, robust clinical trial data are relatively limited when compared with that available for cutaneous melanoma, and management recommendations are frequently based upon consensus opinion and are often extrapolated from the experience in cutaneous melanoma. Importantly, the molecular and immunological differences between non-acral cutaneous melanoma, acral melanoma, mucosal melanoma, and uveal melanoma have critical implications for the appropriate use of systemic therapy in both the advanced disease and adjuvant settings.In this chapter, we review the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy, including molecularly targeted and immunological therapies. We discuss the use of systemic therapy in both the advanced disease setting as well as the adjuvant setting. Finally, we review emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting. More... »

PAGES

1301-1335

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-030-05070-2_62

DOI

http://dx.doi.org/10.1007/978-3-030-05070-2_62

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1124372642


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.516085.f", 
          "name": [
            "Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rapisuwon", 
        "givenName": "Suthee", 
        "id": "sg:person.01155613526.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155613526.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Qin", 
        "givenName": "Yong", 
        "id": "sg:person.01116767046.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116767046.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roszik", 
        "givenName": "Jason", 
        "id": "sg:person.015671353647.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015671353647.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carapeto", 
        "givenName": "Fernando", 
        "id": "sg:person.015546007254.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015546007254.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Sapna", 
        "id": "sg:person.014634030547.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.516091.a", 
          "name": [
            "Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carvajal", 
        "givenName": "Richard D.", 
        "id": "sg:person.0726366600.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2020-01-29", 
    "datePublishedReg": "2020-01-29", 
    "description": "Melanoma is a disease that is remarkably heterogeneous. Even cutaneous melanoma, the most common melanoma subtype, is characterized by important biological and clinical differences between disease arising from nonchronically sun-exposed and chronically sun-exposed skin. Acral melanoma, melanomas which arise from skin on the palms of the hands, soles of the feet, or beneath the nails of the fingers or toes, and extracutaneous melanomas, such as those arising from the mucosal surfaces of the body and from the uveal tract of the eye, are uncommon melanoma subtypes also characterized by biological and clinical characteristics distinct from non-acral cutaneous melanoma and distinct from one another. These melanoma subtypes share a more aggressive natural history as well as a lack of association with ultraviolet radiation when compared with non-acral cutaneous disease.Because of the rarity of acral and extracutaneous melanomas, robust clinical trial data are relatively limited when compared with that available for cutaneous melanoma, and management recommendations are frequently based upon consensus opinion and are often extrapolated from the experience in cutaneous melanoma. Importantly, the molecular and immunological differences between non-acral cutaneous melanoma, acral melanoma, mucosal melanoma, and uveal melanoma have critical implications for the appropriate use of systemic therapy in both the advanced disease and adjuvant settings.In this chapter, we review the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy, including molecularly targeted and immunological therapies. We discuss the use of systemic therapy in both the advanced disease setting as well as the adjuvant setting. Finally, we review emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting.", 
    "editor": [
      {
        "familyName": "Balch", 
        "givenName": "Charles M.", 
        "type": "Person"
      }, 
      {
        "familyName": "Atkins", 
        "givenName": "Michael B.", 
        "type": "Person"
      }, 
      {
        "familyName": "Garbe", 
        "givenName": "Claus", 
        "type": "Person"
      }, 
      {
        "familyName": "Gershenwald", 
        "givenName": "Jeffrey E.", 
        "type": "Person"
      }, 
      {
        "familyName": "Halpern", 
        "givenName": "Allan C.", 
        "type": "Person"
      }, 
      {
        "familyName": "Kirkwood", 
        "givenName": "John M.", 
        "type": "Person"
      }, 
      {
        "familyName": "McArthur", 
        "givenName": "Grant A.", 
        "type": "Person"
      }, 
      {
        "familyName": "Thompson", 
        "givenName": "John F.", 
        "type": "Person"
      }, 
      {
        "familyName": "Sober", 
        "givenName": "Arthur J.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-030-05070-2_62", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-030-05068-9", 
        "978-3-030-05070-2"
      ], 
      "name": "Cutaneous Melanoma", 
      "type": "Book"
    }, 
    "keywords": [
      "non-acral cutaneous melanoma", 
      "systemic therapy", 
      "cutaneous melanoma", 
      "melanoma subtypes", 
      "uveal melanoma", 
      "adjuvant setting", 
      "advanced disease", 
      "extracutaneous melanomas", 
      "acral melanoma", 
      "robust clinical trial data", 
      "common melanoma subtype", 
      "additional clinical settings", 
      "aggressive natural history", 
      "new therapeutic options", 
      "clinical trial data", 
      "lack of association", 
      "neoadjuvant setting", 
      "clinical characteristics", 
      "uveal tract", 
      "mucosal melanoma", 
      "immunological therapies", 
      "therapeutic options", 
      "clinical differences", 
      "cutaneous disease", 
      "immunological characteristics", 
      "mucosal surfaces", 
      "immunological differences", 
      "trial data", 
      "therapy", 
      "melanoma", 
      "natural history", 
      "clinical setting", 
      "consensus opinion", 
      "disease", 
      "subtypes", 
      "appropriate use", 
      "skin", 
      "management recommendations", 
      "setting", 
      "mucosal", 
      "acral", 
      "tract", 
      "nail", 
      "ultraviolet radiation", 
      "differences", 
      "eyes", 
      "rarity", 
      "association", 
      "foot", 
      "use", 
      "toe", 
      "options", 
      "finger", 
      "critical implications", 
      "data", 
      "recommendations", 
      "history", 
      "lack", 
      "experience", 
      "body", 
      "characteristics", 
      "palm", 
      "hand", 
      "opinion", 
      "implications", 
      "radiation", 
      "chapter", 
      "sol", 
      "context", 
      "surface"
    ], 
    "name": "Systemic Therapy for Mucosal, Acral, and Uveal Melanoma", 
    "pagination": "1301-1335", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1124372642"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-030-05070-2_62"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-030-05070-2_62", 
      "https://app.dimensions.ai/details/publication/pub.1124372642"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_178.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-030-05070-2_62"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-05070-2_62'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-05070-2_62'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-05070-2_62'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-05070-2_62'


 

This table displays all metadata directly associated to this object as RDF triples.

210 TRIPLES      22 PREDICATES      93 URIs      86 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-030-05070-2_62 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N1a5c07a745c5432583569dd53e142d35
4 schema:datePublished 2020-01-29
5 schema:datePublishedReg 2020-01-29
6 schema:description Melanoma is a disease that is remarkably heterogeneous. Even cutaneous melanoma, the most common melanoma subtype, is characterized by important biological and clinical differences between disease arising from nonchronically sun-exposed and chronically sun-exposed skin. Acral melanoma, melanomas which arise from skin on the palms of the hands, soles of the feet, or beneath the nails of the fingers or toes, and extracutaneous melanomas, such as those arising from the mucosal surfaces of the body and from the uveal tract of the eye, are uncommon melanoma subtypes also characterized by biological and clinical characteristics distinct from non-acral cutaneous melanoma and distinct from one another. These melanoma subtypes share a more aggressive natural history as well as a lack of association with ultraviolet radiation when compared with non-acral cutaneous disease.Because of the rarity of acral and extracutaneous melanomas, robust clinical trial data are relatively limited when compared with that available for cutaneous melanoma, and management recommendations are frequently based upon consensus opinion and are often extrapolated from the experience in cutaneous melanoma. Importantly, the molecular and immunological differences between non-acral cutaneous melanoma, acral melanoma, mucosal melanoma, and uveal melanoma have critical implications for the appropriate use of systemic therapy in both the advanced disease and adjuvant settings.In this chapter, we review the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy, including molecularly targeted and immunological therapies. We discuss the use of systemic therapy in both the advanced disease setting as well as the adjuvant setting. Finally, we review emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting.
7 schema:editor N52676a93c2ca4b9b83dfa0fc8d5c659c
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Nbe918b9434864bbbaa5e38b69f527aab
11 schema:keywords acral
12 acral melanoma
13 additional clinical settings
14 adjuvant setting
15 advanced disease
16 aggressive natural history
17 appropriate use
18 association
19 body
20 chapter
21 characteristics
22 clinical characteristics
23 clinical differences
24 clinical setting
25 clinical trial data
26 common melanoma subtype
27 consensus opinion
28 context
29 critical implications
30 cutaneous disease
31 cutaneous melanoma
32 data
33 differences
34 disease
35 experience
36 extracutaneous melanomas
37 eyes
38 finger
39 foot
40 hand
41 history
42 immunological characteristics
43 immunological differences
44 immunological therapies
45 implications
46 lack
47 lack of association
48 management recommendations
49 melanoma
50 melanoma subtypes
51 mucosal
52 mucosal melanoma
53 mucosal surfaces
54 nail
55 natural history
56 neoadjuvant setting
57 new therapeutic options
58 non-acral cutaneous melanoma
59 opinion
60 options
61 palm
62 radiation
63 rarity
64 recommendations
65 robust clinical trial data
66 setting
67 skin
68 sol
69 subtypes
70 surface
71 systemic therapy
72 therapeutic options
73 therapy
74 toe
75 tract
76 trial data
77 ultraviolet radiation
78 use
79 uveal melanoma
80 uveal tract
81 schema:name Systemic Therapy for Mucosal, Acral, and Uveal Melanoma
82 schema:pagination 1301-1335
83 schema:productId N3a657a7c9db04a54bee5e1005cc753b3
84 Nfaabe92f4b304aa89e076a51231a5d78
85 schema:publisher N62005e4137364b5eb680954fe33d8442
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124372642
87 https://doi.org/10.1007/978-3-030-05070-2_62
88 schema:sdDatePublished 2022-12-01T06:47
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher Nc608c80ecaa44c04a82fa0067e5d0553
91 schema:url https://doi.org/10.1007/978-3-030-05070-2_62
92 sgo:license sg:explorer/license/
93 sgo:sdDataset chapters
94 rdf:type schema:Chapter
95 N1a5c07a745c5432583569dd53e142d35 rdf:first sg:person.01155613526.20
96 rdf:rest N3031ea9b41924a738229b1cfe4803d70
97 N28328f2d58584b1eb586dc97a7bb2a88 schema:familyName Gershenwald
98 schema:givenName Jeffrey E.
99 rdf:type schema:Person
100 N2d4271136ce0412d869dc1c6972e0a80 rdf:first N28328f2d58584b1eb586dc97a7bb2a88
101 rdf:rest N483650d985ee4f54a6a853743b91528a
102 N2f6f373a058a49be8a121b76ca5974de rdf:first sg:person.014634030547.08
103 rdf:rest Nd7a886fe49504ea08d4a3514fbd86523
104 N3031ea9b41924a738229b1cfe4803d70 rdf:first sg:person.01116767046.03
105 rdf:rest N6b167a8776bb4573bd2218c2444f7185
106 N3a657a7c9db04a54bee5e1005cc753b3 schema:name doi
107 schema:value 10.1007/978-3-030-05070-2_62
108 rdf:type schema:PropertyValue
109 N3f90541c118c419eb4ddf7a15fc14a82 rdf:first N43f350b2c87d4105a45da06479ea58de
110 rdf:rest N9af9f523c44c4a5db2bbef18db5384c2
111 N43f350b2c87d4105a45da06479ea58de schema:familyName McArthur
112 schema:givenName Grant A.
113 rdf:type schema:Person
114 N483650d985ee4f54a6a853743b91528a rdf:first N9f01b245838742ff92158c7c54275f6d
115 rdf:rest Ne2f39fa72f5841fd8a6b67efd936e0f2
116 N48937ae52c9743b89a15960efccbee43 rdf:first sg:person.015546007254.28
117 rdf:rest N2f6f373a058a49be8a121b76ca5974de
118 N52676a93c2ca4b9b83dfa0fc8d5c659c rdf:first Nb194f79178804e3699f478ab97d4aafd
119 rdf:rest Nc93b046af07346f7842baf8759801ef2
120 N52733994a0a644869fd81bf55f2ca050 rdf:first N827056f0d84d4a7499ca4f2c9bce47f7
121 rdf:rest rdf:nil
122 N612db91b842048f68ee24320d70a7d72 schema:familyName Atkins
123 schema:givenName Michael B.
124 rdf:type schema:Person
125 N62005e4137364b5eb680954fe33d8442 schema:name Springer Nature
126 rdf:type schema:Organisation
127 N6b167a8776bb4573bd2218c2444f7185 rdf:first sg:person.015671353647.55
128 rdf:rest N48937ae52c9743b89a15960efccbee43
129 N800a1346556a4ca0b19760da116df97e schema:familyName Garbe
130 schema:givenName Claus
131 rdf:type schema:Person
132 N827056f0d84d4a7499ca4f2c9bce47f7 schema:familyName Sober
133 schema:givenName Arthur J.
134 rdf:type schema:Person
135 N9af9f523c44c4a5db2bbef18db5384c2 rdf:first Na6ba0e27cd85424e9b908824615ef944
136 rdf:rest N52733994a0a644869fd81bf55f2ca050
137 N9f01b245838742ff92158c7c54275f6d schema:familyName Halpern
138 schema:givenName Allan C.
139 rdf:type schema:Person
140 Na6ba0e27cd85424e9b908824615ef944 schema:familyName Thompson
141 schema:givenName John F.
142 rdf:type schema:Person
143 Naf6b55c5d52f444c8031a60242bbaf42 rdf:first N800a1346556a4ca0b19760da116df97e
144 rdf:rest N2d4271136ce0412d869dc1c6972e0a80
145 Nb194f79178804e3699f478ab97d4aafd schema:familyName Balch
146 schema:givenName Charles M.
147 rdf:type schema:Person
148 Nbe918b9434864bbbaa5e38b69f527aab schema:isbn 978-3-030-05068-9
149 978-3-030-05070-2
150 schema:name Cutaneous Melanoma
151 rdf:type schema:Book
152 Nc608c80ecaa44c04a82fa0067e5d0553 schema:name Springer Nature - SN SciGraph project
153 rdf:type schema:Organization
154 Nc93b046af07346f7842baf8759801ef2 rdf:first N612db91b842048f68ee24320d70a7d72
155 rdf:rest Naf6b55c5d52f444c8031a60242bbaf42
156 Nd7a886fe49504ea08d4a3514fbd86523 rdf:first sg:person.0726366600.25
157 rdf:rest rdf:nil
158 Ne2f39fa72f5841fd8a6b67efd936e0f2 rdf:first Neb761c5ca29641c19716a42fb753ed08
159 rdf:rest N3f90541c118c419eb4ddf7a15fc14a82
160 Neb761c5ca29641c19716a42fb753ed08 schema:familyName Kirkwood
161 schema:givenName John M.
162 rdf:type schema:Person
163 Nfaabe92f4b304aa89e076a51231a5d78 schema:name dimensions_id
164 schema:value pub.1124372642
165 rdf:type schema:PropertyValue
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
170 schema:name Oncology and Carcinogenesis
171 rdf:type schema:DefinedTerm
172 sg:person.01116767046.03 schema:affiliation grid-institutes:grid.240145.6
173 schema:familyName Qin
174 schema:givenName Yong
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116767046.03
176 rdf:type schema:Person
177 sg:person.01155613526.20 schema:affiliation grid-institutes:grid.516085.f
178 schema:familyName Rapisuwon
179 schema:givenName Suthee
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155613526.20
181 rdf:type schema:Person
182 sg:person.014634030547.08 schema:affiliation grid-institutes:grid.240145.6
183 schema:familyName Patel
184 schema:givenName Sapna
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08
186 rdf:type schema:Person
187 sg:person.015546007254.28 schema:affiliation grid-institutes:grid.240145.6
188 schema:familyName Carapeto
189 schema:givenName Fernando
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015546007254.28
191 rdf:type schema:Person
192 sg:person.015671353647.55 schema:affiliation grid-institutes:grid.240145.6
193 schema:familyName Roszik
194 schema:givenName Jason
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015671353647.55
196 rdf:type schema:Person
197 sg:person.0726366600.25 schema:affiliation grid-institutes:grid.516091.a
198 schema:familyName Carvajal
199 schema:givenName Richard D.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25
201 rdf:type schema:Person
202 grid-institutes:grid.240145.6 schema:alternateName Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
203 schema:name Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
204 rdf:type schema:Organization
205 grid-institutes:grid.516085.f schema:alternateName Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA
206 schema:name Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA
207 rdf:type schema:Organization
208 grid-institutes:grid.516091.a schema:alternateName Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA
209 schema:name Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA
210 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...